Leonard Hayflick, Ph.D., is Professor of Anatomy at the University of California, San Francisco. He has served on the editorial boards of more than 10 professional journals and was editor-in-chief of the international journal Experimental Gerontology for 13 years. He was a founding member of the Council of the National Institute on Aging and a consultant to the National Cancer Institute and the World Health Organization. He now serves as a member of several scientific advisory boards, including the Board of Directors of the American Federation for Aging Research. Dr. Hayflick is best known for his research in cell biology and mycoplasmology, having discovered in 1962 that, contrary to accepted belief, cultured normal human and animal cells have a limited capacity for replication. This phenomenon, known as “The Hayflick Limit,” overturned a dogma that existed since early in the 20th century and focused attention on the cell as the fundamental location of age changes. Also in 1962, Dr. Hayflick discovered that the etiological agent of primary atypical pneumonia (“walking pneumonia”) was a mycoplasma (Mycoplasma pneumoniae), the smallest free-living microorganism. In 1968, Dr. Hayflick was appointed Professor of Medical Microbiology at the Stanford University School of Medicine. In 1982, he moved to the University of Florida, Gainesville, where he became Director of the Center for Gerontological Studies, Professor of Zoology, and Professor of Microbiology and Immunology. Dr. Hayflick demonstrated for the first time that mortal and immortal mammalian cells existed, and this distinction is the basis for much modern cancer research. He determined the existence and nuclear location of a counting mechanism in normal human cells now known to be telomere shortening. Dr. Hayflick developed WI-38, the first normal human diploid cell strain for studies on human aging and for research use throughout the world wherever a normal human cell is required; it is now used for the manufacture of most of the world’s human virus vaccines. Dr. Hayflick is the recipient of more than 25 major awards, including the $20,000 Brookdale Award and the Kleemeier Award from the Gerontological Society of America. In 1997, he was elected Academician and Foreign Member of the Ukrainian Academy of Medical Sciences. In 1998, he was elected corresponding member of the Société de Biologie of France. In 1999, he was presented with the van Weezel Award by the European Society for Animal Cell Technology and the Lord Cohen of Birkenhead Medal by the British Society for Research on Aging. Dr. Hayflick is author of the popular book, How and Why We Age (New York: Ballantine Books, 1994), now translated into 10 foreign languages. He is a Fellow of the American Association for the Advancement of Science, an Honorary Member of the Tissue Culture Association, and is one of the 1,000 most cited contemporary scientists in the world.

Day 1: Morning Presentation